Adaptive Radiation Therapy for Faster Prostate Cancer Treatment
Part of Cancer, Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new way to deliver radiation therapy for prostate cancer using adaptive techniques—meaning the treatment adjusts based on imaging done right before each session. The goal is to safely give higher doses in fewer treatments, reducing your overall therapy time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be enrolled in the PERa registry at CHUM and have previously consented to be contacted about research studies
- You must have been randomly selected by the study team to receive this experimental treatment approach
- You cannot have a pacemaker or other implanted metal devices that would interfere with MRI imaging
- You cannot have a hip replacement or significant pelvic metal implants that create imaging problems
- You must not have claustrophobia or other conditions that prevent you from lying still in an MRI machine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving radiation to the prostate and pelvic lymph nodes. It also tests two different instructions for how full your bladder should be during treatment. The goal is to see which approach works better and is easier for patients.
This trial tests a shorter course of radiation therapy with an extra 'boost' to the most aggressive part of the tumor, combined with hormone therapy, for men with high-risk or locally advanced prostate cancer that has not spread outside the pelvis.
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial studies a “daily adaptive” way of planning and delivering radiation after prostate surgery to treat prostate cancer that is coming back locally. It may help target the tumor more precisely while limiting radiation to healthy tissue.
This trial tests a very short course of daily radiation that adapts to your body's changes. It aims to be just as effective as standard treatment but more convenient.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.